NATIONAL BANK OF CANADA /FI/ - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$520
+32.3%
2,6000.0%0.00%
Q1 2023$393
-72.8%
2,6000.0%0.00%
Q4 2022$1,443
-51.9%
2,6000.0%0.00%
Q3 2022$3,000
+50.0%
2,6000.0%0.00%
Q2 2022$2,000
-33.3%
2,6000.0%0.00%
Q1 2022$3,000
-50.0%
2,6000.0%0.00%
Q4 2021$6,0002,6000.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders